These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8982953)

  • 1. Congenital nephrotic syndrome: a novel phenotype of type I carbohydrate-deficient glycoprotein syndrome.
    van der Knaap MS; Wevers RA; Monnens L; Jakobs C; Jaeken J; van Wijk JA
    J Inherit Metab Dis; 1996; 19(6):787-91. PubMed ID: 8982953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate deficient glycoprotein syndrome type I: a cause of cerebellar vermis hypoplasia.
    Worthington S; Arbuckle S; Nelson P; Carey W; Lipson A; Fagan E
    J Paediatr Child Health; 1997 Dec; 33(6):531-4. PubMed ID: 9484687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate deficient glycoprotein syndrome type Ia.
    Chu KL; Chien YH; Tsai CE; Freeze HH; Eklund E; Hwu WL
    J Formos Med Assoc; 2004 Sep; 103(9):721-3. PubMed ID: 15361947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital disorders of glycosylation: a rare cause of nephrotic syndrome.
    Sinha MD; Horsfield C; Komaromy D; Booth CJ; Champion MP
    Nephrol Dial Transplant; 2009 Aug; 24(8):2591-4. PubMed ID: 19474279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls.
    Asteggiano CG; Papazoglu M; Bistué Millón MB; Peralta MF; Azar NB; Spécola NS; Guelbert N; Suldrup NS; Pereyra M; Dodelson de Kremer R
    Pediatr Res; 2018 Dec; 84(6):837-841. PubMed ID: 30397276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic dilemmas in four infants with nephrotic syndrome, microcephaly and severe developmental delay.
    de Vries BB; van'tHoff WG; Surtees RA; Winter RM
    Clin Dysmorphol; 2001 Apr; 10(2):115-21. PubMed ID: 11310991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
    Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
    Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CDG (congenital disorders of glycosylation). Differential hereditary ataxia in adulthood diagnosis].
    Bubel S; Peters V; Klein C; Hackler R; Schaefer JR; Hagenah J; Hoffmann GF; Vieregge P
    Nervenarzt; 2002 Aug; 73(8):754-60. PubMed ID: 12242963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital nephrotic syndrome with dysmorphic features and death in early infancy: Answers.
    Park JH; Weissensteiner M; Wagner O; Wada Y; Rust S; Reunert J; Marquardt T
    Pediatr Nephrol; 2016 Aug; 31(8):1283-6. PubMed ID: 25956699
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurophysiological findings in a case of carbohydrate-deficient glycoprotein (CDG) syndrome type I with phosphomannomutase deficiency.
    Veneselli E; Biancheri R; Di Rocco M; Tortorelli S
    Eur J Paediatr Neurol; 1998; 2(5):239-44. PubMed ID: 10726826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of the carbohydrate-deficient glycoprotein syndrome type 1 (CDGS type 1) with normal phosphomannomutase activity.
    Charlwood J; Clayton P; Johnson A; Keir G; Mian N; Winchester B
    J Inherit Metab Dis; 1997 Nov; 20(6):817-26. PubMed ID: 9427152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An atypical carbohydrate-deficient glycoprotein (CDG) syndrome patient in South Africa.
    du Plessis JA; Pretorius PJ; Lippert MM; Knoll DP; Erasmus E; van der Westhuizen FH; Mienie LJ
    S Afr Med J; 2001 May; 91(5):392-4. PubMed ID: 11455799
    [No Abstract]   [Full Text] [Related]  

  • 15. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.
    de Lonlay P; Seta N; Barrot S; Chabrol B; Drouin V; Gabriel BM; Journel H; Kretz M; Laurent J; Le Merrer M; Leroy A; Pedespan D; Sarda P; Villeneuve N; Schmitz J; van Schaftingen E; Matthijs G; Jaeken J; Korner C; Munnich A; Saudubray JM; Cormier-Daire V
    J Med Genet; 2001 Jan; 38(1):14-9. PubMed ID: 11134235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).
    Carchon H; Van Schaftingen E; Matthijs G; Jaeken J
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):155-65. PubMed ID: 10571009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital disorders of glycosylation.
    Jaeken J
    Handb Clin Neurol; 2013; 113():1737-43. PubMed ID: 23622397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal involvement in PMM2-CDG, a mini-review.
    Altassan R; Witters P; Saifudeen Z; Quelhas D; Jaeken J; Levtchenko E; Cassiman D; Morava E
    Mol Genet Metab; 2018 Mar; 123(3):292-296. PubMed ID: 29229467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).
    Grünewald S
    Biochim Biophys Acta; 2009 Sep; 1792(9):827-34. PubMed ID: 19272306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).
    Barone R; Sturiale L; Fiumara A; Uziel G; Garozzo D; Jaeken J
    J Inherit Metab Dis; 2007 Feb; 30(1):107. PubMed ID: 17186415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.